AzTrials
AzTrials

StrokeCHAMPSNCT02450760

Connected Health Blood Pressure Monitoring In Stroke and TIA Patients

A study testing Social incentive in people with Stroke and Ischemic Attack, Transient, run by University of Pennsylvania at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this pilot project is to assess adherence with home blood pressure monitoring in hypertensive patients with a history of cerebral infarction and to determine if a social incentive improves adherence with monitoring. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Ischemic Attack, Transient
What is being tested?
Social incentive
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteUnited States
Study dates
Nov 2015to Jul 2021
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult, age ≥ 18 years
  • History of ischemic stroke or high risk TIA (defined by ABCD2 ≥ 4)between 2 weeks and 12 months prior to enrollment
  • Hypertensive at time of enrollment, defined by SBP>140 mm Hg or DBP >90 mm Hg at the time of study screening
  • Must own a smart phone capable of interacting with the connected blood pressure cuff (Apple iPhone 3GS or higher; Android 4.0 or higher with Bluetooth connectivity)
  • Willingness and ability to sign informed consent by patient

Who cannot join

  • Moderate or severe disability, defined by modified Rankin Scale ≥ 3.
  • Expected residence in a rehabilitation hospital, nursing facility or assisted living community during the study period.
  • Upper arm circumference <9 inches or >17 inches
  • Inability to monitor BP in both of the upper arms (i.e. history of bilateral radical mastectomy, bilateral severe subclavian stenosis, or bilateral arterial venous fistulas for dialysis).
  • Blood pressure discrepancy between arms of >10 mm Hg.
  • Inability to follow-up at 90 days and return BP monitor
  • Active participation in another clinical trial
  • Pregnant women

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

The goal of this pilot project is to assess adherence with home blood pressure monitoring in hypertensive patients with a history of cerebral infarction and to determine if a social incentive improves adherence with monitoring. Enrolled subjects will all have a history of cerebral infarction and uncontrolled blood pressure, defined by SBP>140 or DBP>90 mm Hg at the time of enrollment. To be eligible subjects will also be required to own a smart phone (iOS or Android operating system). After enrollment, patients will be given a home blood pressure cuff with instructions to monitor their BP twice daily for 90 days. Subjects will be randomly assigned to a social incentive program, in which a social supporter receives updates via email and/or text message on the subject's adherence with BP monitoring and their average blood pressure. This study will provide important pilot data which will inform the design of future studies utilizing connected health and automated systems to improve home blood pressure monitoring and blood pressure control in patients with a history of stroke.

Being tested
Social incentive
Medical subject headings
Stroke, Ischemic Attack, Transient

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Social incentiveOther

    Quantify adherence to 90 days of home blood pressure monitoring and to determine if a social incentive improves adherence

Study groups in NCT02450760
Study groupRoleWhat they receive
ControlOtherSubjects will take their blood pressure twice daily using the provided Withings blood pressure cuff. If subjects miss blood pressure readings, they will receive automated alerts reminding them to take their blood pressure. Subjects will also receive weekly emails with their blood pressure data for the week.
Receives: Other: Social incentive
Social IncentiveOtherSubjects will take their blood pressure twice daily using the provided Withings blood pressure cuff. Subjects in this arm will also identify a social supporter who may help subjects adhere to daily blood pressure readings. If the subject misses blood pressure readings, they will receive automated alerts reminding them to take their blood pressure. The identified social supporter will also receive these alerts, with the expectation that the social supporter will remind the subject to take their blood pressure. Both the subject and the social supporter will also receive weekly emails with their blood pressure data for the week.
Receives: Other: Social incentive

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adherence With Home Blood Pressure Monitoring, Defined by the Proportion of Home Blood Pressure Recordings Successfully Completed

    Percentage of requested blood pressure measurements completed. Note that subjects were enrolled for 90 +/- 7 days, and so this calculation was completed at day 83, rather than day 90.

    Measured: 90 Days

Secondary outcomes (7)
  1. Change in Systolic Blood Pressure Over Study Period

    Difference in systolic blood pressure from the first 7 days of measurement to the last 7 days of measurement for each subject

    Measured: 90 days

  2. Number of Physician Visits

    Measured: 90 days

  3. Number of Emergency Department Visits

    Measured: 90 days

  4. Number of Changes in Antihypertensive Medications (Dose Adjustment or Addition of a New Agent)

    Measured: 90 days

  5. Number of Participates That Perceived the Blood Pressure Monitoring Device to be Easy to Use

    Number of patients who felt that device was easy or very easy to use

    Measured: 90 days

  6. Number of Patients That Perceived Blood Pressure Monitoring to be Useful

    Number of participants who felt that BP monitoring was useful or very useful

    Measured: 90 days

  7. Number of Patients Who Felt They Had Well-controlled Blood Pressure

    Patients perception of whether or not BP was well controlled

    Measured: 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 May 2015 (estimated)
  2. Study startNov 2015
  3. Primary completionJul 2018
  4. Study completionJul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02450760
Sponsor's protocol ID
821743
Acronym
CHAMPS
Status last verified
Dec 2021
First submitted
18 May 2015
Last updated
17 Feb 2022
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Social incentive in people with Stroke and Ischemic Attack, Transient, run by University of Pennsylvania at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 17 Feb 2022). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adherence With Home Blood Pressure Monitoring, Defined by the Proportion of Home Blood Pressure Recordings Successfully Completed (time frame: 90 Days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in